News
The NHS in England has announced that it is piloting home testing for coronavirus, as the number of confirmed cases of COVID-19 in the UK went up to 13 on Sunday (23 February).
The news follows after the company’s ResAppDx-EU version 2 smartphone app was approved by the Australian TGA as a Class IIa medical device.
A recently published analysis of eight digital studies found a median dropoff of 5.5 days, as well as a predominantly young and white pool of participants.
The platform was designed to provide patients with limited English proficiency access to speciality care.
The high street beauty and health retailer is taking one step further to introduce digital services for its customers.
The system can complete a quantitative analysis of lung lesions in 2-3 seconds.
The accelerator will focus on human centered design, data integration, data interoperability and third-party solution integration.
Both CGM competitors announced integrations with Insulet yesterday during the Advanced Technologies & Treatment for Diabetes Congress in Madrid.
Endeavour Vision led the round with participation from Kaiser Permanente Ventures and Generator Ventures.
Pear plans to roll Functional Solutions’ visual programming and custom fitness content into its enterprise SaaS.